Controlled Substances; determine whether a controlled substance has been adulterated; authorize the use of testing equipment
Summary
SB 6 amends Georgia law governing drugs and controlled substances to clarify that certain drug analysis equipment may be used to test whether a controlled substance or its packaging has been adulterated and contains a synthetic opioid. The bill specifically states that this testing equipment will not be treated as a “drug related object” under the Georgia Controlled Substances Act when used for that purpose.
The measure is framed as a narrow exception to existing drug paraphernalia restrictions. It preserves the broader application of Georgia’s drug laws and related federal manufacturing standards, while carving out legal protection for testing tools used to detect adulteration in controlled substances and packaging.
Impact
The bill modifies Code Section 26-3-22 of the Official Code of Georgia Annotated and affects the interaction between the Georgia Drug and Cosmetic Act and the Georgia Controlled Substances Act. Its practical effect is to reduce legal risk for possession or use of drug-checking equipment when the equipment is used to determine whether a controlled substance or its packaging has been adulterated with a synthetic opioid. This may affect harm-reduction programs, public health organizations, law enforcement interpretations, and others who use or encounter drug testing tools.
Sentiment
The bill appears to have broad bipartisan support and little visible opposition. It passed the Senate 55-0 and the House 170-0, indicating unanimous approval in both chambers. The voting record suggests the measure was viewed as a targeted, noncontroversial clarification rather than a major policy shift.
Contention
No committee debate or recorded objections are provided, and the unanimous votes indicate no significant contention in the available record. The main policy issue implicit in the bill is the balance between drug enforcement laws and allowing testing equipment to identify adulterated substances, especially synthetic opioids. Any potential concern would likely center on whether the exception could be interpreted too broadly, but the text limits it to equipment used for adulteration testing.